Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02202109 · ClinicalTrials.gov registry record · NA

Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida

A NA study of Cervical Cancer, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
602
Enrollment target
1
Study location

NCT02202109: Completed NA study of Cervical Cancer, sponsored by University of Miami.

NCT02202109 is a NA study of Cervical Cancer that has completed, run by University of Miami. The registered enrollment target is 602 participants, roughly in line with the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02202109, a NA study of Cervical Cancer, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
602 participants
Enrollment target
1
Study location

Study Summary

The study will test the significance of community health worker (CHW) participation by comparing self-sampling provided by a community health worker and self-sampling provided by mail. The study will enroll 700 participants in communities that lack access to medical care in South Florida.

Primary Outcome

The primary outcome is having had a self-sampling done since the initial evaluation. Participants who test negative will be encouraged to rescreen while Participants who test positive for HPV will be navigated to appropriate follow-up care. The CHWs will follow up with participants who do not return the kit within 60 days.

Conditions Studied

Interventions

  • BEHAVIORAL CHW and Self-sampling for Cervical Cancer
  • BEHAVIORAL Mailed Self Sampler

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 602 participants
Start Date 2015-01
Est. Completion 2017-08
Phase NA
University of Miami

721 total trials

What the finished NCT02202109 record still lists

NCT02202109 is an interventional study that assigns participants to a tested intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which CHW and Self-sampling for Cervical Cancer is the first listed.

NCT02202109 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02202109 about?

NCT02202109 is a clinical study titled "Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida". The study will test the significance of community health worker (CHW) participation by comparing self-sampling provided by a community health worker and self-sampling provided by mail. The study will enroll 700 participants in communities that lack access to medical care in South Florida.

What is the current status of trial NCT02202109?

This trial is currently completed. It is a NA study. The enrollment target is 602 participants. The study started on 2015-01. Estimated completion is 2017-08.

What conditions does trial NCT02202109 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT02202109?

The interventions under investigation include: CHW and Self-sampling for Cervical Cancer (BEHAVIORAL), Mailed Self Sampler (BEHAVIORAL).

Who is sponsoring clinical trial NCT02202109?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02202109 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02202109's enrollment target sits among peer trials

602 25th of 144 higher than 120 of 144 other Cervical Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03849443 · 604 participants · Early Phase 1

    Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery

  • NCT05238922 · 604 participants · Phase 1

    Study of INCB123667 in Subjects With Advanced Solid Tumors

  • NCT06040541 · 604 participants · Phase 1

    Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02202109, the US trial registry maintained by the National Library of Medicine. NCT02202109 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.